Lastinem 125mg/125mg Injection
Marketer
Venus Remedies Ltd
Salt Composition
Imipenem (125mg) + Cilastatin (125mg)
Overview Lastinem 125mg/125mg Injection
Combiflox 125 mg/125 mg Injection, a dual-antibiotic formulation, combats severe bacterial infections. Administered only by a healthcare provider, this medication requires adherence to the prescribed schedule; complete the full course regardless of symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) may occur but typically resolve. Worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, breathing difficulties). Inform your physician of all other medications, including those for pre-existing conditions, before using Combiflox. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While typically not impairing driving ability, avoid operating vehicles if drowsiness or dizziness occurs.
Uses of Lastinem 125mg/125mg Injection
Life-threatening bacterial infestations
Major Benefits of Lastinem 125mg/125mg Injection:
This medication will be administered by your physician or their nursing staff; self-medication is strictly prohibited.
Common Side effects of Lastinem 125mg/125mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Lastinem 125mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Lastinem 125mg/125mg Injection works:
Lastinem 125 mg/125 mg injection unites imipenem, an antibiotic, with cilastatin, a dehydropeptidase I inhibitor. Imipenem's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Cilastatin safeguards imipenem's efficacy by inhibiting dehydropeptidase I, an enzyme that otherwise rapidly degrades it. This synergistic action extends imipenem's therapeutic presence within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Lastinem 125 mg/125 mg Injection with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Lastinem 125 mg/125 mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Lastinem 125 mg/125 mg Injection during lactation is likely safe. Available human data indicate minimal infant risk associated with the medication.
DrivingUNSAFE
Administering Lastinem 125 mg/125 mg Injection might induce adverse reactions impairing driving capabilities. Certain drug-related side effects, including hallucinations (visual, auditory, or sensory), can compromise safe driving in some individuals.
KidneyCAUTION
Patients with kidney impairment should use Lastinem 125 mg/125 mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lastinem 125 mg/125 mg Injection to individuals with hepatic impairment. Seek medical advice.
What if you forget to take Lastinem 125mg/125mg Injection :
Omit a Lastinem 125 mg/125 mg Injection dose? Seek medical advice immediately.
Facts to Know About Lastinem 125mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently